Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine
Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2,...
Gespeichert in:
Veröffentlicht in: | Neurotoxicology and teratology 2011-01, Vol.33 (1), p.176-184 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 184 |
---|---|
container_issue | 1 |
container_start_page | 176 |
container_title | Neurotoxicology and teratology |
container_volume | 33 |
creator | Smith, Lynne M LaGasse, Linda L Derauf, Chris Newman, Elana Shah, Rizwan Haning, William Arria, Amelia Huestis, Marilyn Strauss, Arthur Della Grotta, Sheri Dansereau, Lynne M Lin, Hai Lester, Barry M |
description | Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has mod |
doi_str_mv | 10.1016/j.ntt.2010.10.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3033584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0892036210001868</els_id><sourcerecordid>860378466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c537t-465b7fcda58d614d30e4e16fdede944ec9b519140000f7f9535f63d661da0a9f3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAUtBCILoUfwAX5ximLHTtOIqRKqOJLKuJQOFte-yXxktjBdlbdf1-nWyrKgdPTs2fm2TMPodeUbCmh4t1-61LaluSu3xLCn6ANbeqyaGvWPEUb0rRlQZgoz9CLGPeEkFpQ8hydlbSsBGd0g_pvPvmAlTNY-97ZZA-A_ZK0nyDiNAS_9MNaAfARVIjYd1j1gK3DerCjCeAw3Mw-gsHJ4zn3KqkRT5AGNc0DJDVZBy_Rs06NEV7d13P089PHH5dfiqvvn79efrgqdMXqVHBR7epOG1U1RlBuGAEOVHQGDLScg253FW0pz18hXd21Fas6wYwQ1Cii2o6do4uT7rzsJjAaXApqlHOwkwpH6ZWVj2-cHWTvD5IRxqqGZ4G39wLB_14gJjnZqGEclQO_RNkIwuqGC5GR9ITUwccYoHuYQolc85F7mfORaz7rUc4nc978_bwHxp9AMuD9CQDZpIOFIKO24DQYG0Anabz9r_zFP2w9Wme1Gn_BEeLeL8Fl9yWVsZREXq8Lsu4HzXbSRjTsFsvquKM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>860378466</pqid></control><display><type>article</type><title>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Smith, Lynne M ; LaGasse, Linda L ; Derauf, Chris ; Newman, Elana ; Shah, Rizwan ; Haning, William ; Arria, Amelia ; Huestis, Marilyn ; Strauss, Arthur ; Della Grotta, Sheri ; Dansereau, Lynne M ; Lin, Hai ; Lester, Barry M</creator><creatorcontrib>Smith, Lynne M ; LaGasse, Linda L ; Derauf, Chris ; Newman, Elana ; Shah, Rizwan ; Haning, William ; Arria, Amelia ; Huestis, Marilyn ; Strauss, Arthur ; Della Grotta, Sheri ; Dansereau, Lynne M ; Lin, Hai ; Lester, Barry M</creatorcontrib><description>Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has modest motor effects at 1 year that are mostly resolved by 3 years.</description><identifier>ISSN: 0892-0362</identifier><identifier>EISSN: 1872-9738</identifier><identifier>DOI: 10.1016/j.ntt.2010.10.004</identifier><identifier>PMID: 21256431</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bayley ; Case-Control Studies ; Child Behavior - drug effects ; Child Behavior - psychology ; Child Development - drug effects ; Child, Preschool ; Cognition - drug effects ; Cross-Sectional Studies ; Emergency ; Female ; Humans ; Infant ; Infant Behavior - drug effects ; Infant Behavior - psychology ; Infant, Newborn ; Longitudinal Studies ; Male ; Medical Education ; Methamphetamine - toxicity ; Motor Activity - drug effects ; Neurodevelopment ; Peabody ; Pregnancy ; Prenatal exposure ; Prenatal Exposure Delayed Effects - chemically induced ; Prenatal Exposure Delayed Effects - physiopathology ; Prenatal Exposure Delayed Effects - psychology ; Social Class ; Surveys and Questionnaires</subject><ispartof>Neurotoxicology and teratology, 2011-01, Vol.33 (1), p.176-184</ispartof><rights>Elsevier Inc.</rights><rights>2010 Elsevier Inc.</rights><rights>Copyright © 2010 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c537t-465b7fcda58d614d30e4e16fdede944ec9b519140000f7f9535f63d661da0a9f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ntt.2010.10.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,778,782,883,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21256431$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Lynne M</creatorcontrib><creatorcontrib>LaGasse, Linda L</creatorcontrib><creatorcontrib>Derauf, Chris</creatorcontrib><creatorcontrib>Newman, Elana</creatorcontrib><creatorcontrib>Shah, Rizwan</creatorcontrib><creatorcontrib>Haning, William</creatorcontrib><creatorcontrib>Arria, Amelia</creatorcontrib><creatorcontrib>Huestis, Marilyn</creatorcontrib><creatorcontrib>Strauss, Arthur</creatorcontrib><creatorcontrib>Della Grotta, Sheri</creatorcontrib><creatorcontrib>Dansereau, Lynne M</creatorcontrib><creatorcontrib>Lin, Hai</creatorcontrib><creatorcontrib>Lester, Barry M</creatorcontrib><title>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</title><title>Neurotoxicology and teratology</title><addtitle>Neurotoxicol Teratol</addtitle><description>Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has modest motor effects at 1 year that are mostly resolved by 3 years.</description><subject>Bayley</subject><subject>Case-Control Studies</subject><subject>Child Behavior - drug effects</subject><subject>Child Behavior - psychology</subject><subject>Child Development - drug effects</subject><subject>Child, Preschool</subject><subject>Cognition - drug effects</subject><subject>Cross-Sectional Studies</subject><subject>Emergency</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant Behavior - drug effects</subject><subject>Infant Behavior - psychology</subject><subject>Infant, Newborn</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical Education</subject><subject>Methamphetamine - toxicity</subject><subject>Motor Activity - drug effects</subject><subject>Neurodevelopment</subject><subject>Peabody</subject><subject>Pregnancy</subject><subject>Prenatal exposure</subject><subject>Prenatal Exposure Delayed Effects - chemically induced</subject><subject>Prenatal Exposure Delayed Effects - physiopathology</subject><subject>Prenatal Exposure Delayed Effects - psychology</subject><subject>Social Class</subject><subject>Surveys and Questionnaires</subject><issn>0892-0362</issn><issn>1872-9738</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk1v1DAUtBCILoUfwAX5ximLHTtOIqRKqOJLKuJQOFte-yXxktjBdlbdf1-nWyrKgdPTs2fm2TMPodeUbCmh4t1-61LaluSu3xLCn6ANbeqyaGvWPEUb0rRlQZgoz9CLGPeEkFpQ8hydlbSsBGd0g_pvPvmAlTNY-97ZZA-A_ZK0nyDiNAS_9MNaAfARVIjYd1j1gK3DerCjCeAw3Mw-gsHJ4zn3KqkRT5AGNc0DJDVZBy_Rs06NEV7d13P089PHH5dfiqvvn79efrgqdMXqVHBR7epOG1U1RlBuGAEOVHQGDLScg253FW0pz18hXd21Fas6wYwQ1Cii2o6do4uT7rzsJjAaXApqlHOwkwpH6ZWVj2-cHWTvD5IRxqqGZ4G39wLB_14gJjnZqGEclQO_RNkIwuqGC5GR9ITUwccYoHuYQolc85F7mfORaz7rUc4nc978_bwHxp9AMuD9CQDZpIOFIKO24DQYG0Anabz9r_zFP2w9Wme1Gn_BEeLeL8Fl9yWVsZREXq8Lsu4HzXbSRjTsFsvquKM</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Smith, Lynne M</creator><creator>LaGasse, Linda L</creator><creator>Derauf, Chris</creator><creator>Newman, Elana</creator><creator>Shah, Rizwan</creator><creator>Haning, William</creator><creator>Arria, Amelia</creator><creator>Huestis, Marilyn</creator><creator>Strauss, Arthur</creator><creator>Della Grotta, Sheri</creator><creator>Dansereau, Lynne M</creator><creator>Lin, Hai</creator><creator>Lester, Barry M</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</title><author>Smith, Lynne M ; LaGasse, Linda L ; Derauf, Chris ; Newman, Elana ; Shah, Rizwan ; Haning, William ; Arria, Amelia ; Huestis, Marilyn ; Strauss, Arthur ; Della Grotta, Sheri ; Dansereau, Lynne M ; Lin, Hai ; Lester, Barry M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c537t-465b7fcda58d614d30e4e16fdede944ec9b519140000f7f9535f63d661da0a9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Bayley</topic><topic>Case-Control Studies</topic><topic>Child Behavior - drug effects</topic><topic>Child Behavior - psychology</topic><topic>Child Development - drug effects</topic><topic>Child, Preschool</topic><topic>Cognition - drug effects</topic><topic>Cross-Sectional Studies</topic><topic>Emergency</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant Behavior - drug effects</topic><topic>Infant Behavior - psychology</topic><topic>Infant, Newborn</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical Education</topic><topic>Methamphetamine - toxicity</topic><topic>Motor Activity - drug effects</topic><topic>Neurodevelopment</topic><topic>Peabody</topic><topic>Pregnancy</topic><topic>Prenatal exposure</topic><topic>Prenatal Exposure Delayed Effects - chemically induced</topic><topic>Prenatal Exposure Delayed Effects - physiopathology</topic><topic>Prenatal Exposure Delayed Effects - psychology</topic><topic>Social Class</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Lynne M</creatorcontrib><creatorcontrib>LaGasse, Linda L</creatorcontrib><creatorcontrib>Derauf, Chris</creatorcontrib><creatorcontrib>Newman, Elana</creatorcontrib><creatorcontrib>Shah, Rizwan</creatorcontrib><creatorcontrib>Haning, William</creatorcontrib><creatorcontrib>Arria, Amelia</creatorcontrib><creatorcontrib>Huestis, Marilyn</creatorcontrib><creatorcontrib>Strauss, Arthur</creatorcontrib><creatorcontrib>Della Grotta, Sheri</creatorcontrib><creatorcontrib>Dansereau, Lynne M</creatorcontrib><creatorcontrib>Lin, Hai</creatorcontrib><creatorcontrib>Lester, Barry M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurotoxicology and teratology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Lynne M</au><au>LaGasse, Linda L</au><au>Derauf, Chris</au><au>Newman, Elana</au><au>Shah, Rizwan</au><au>Haning, William</au><au>Arria, Amelia</au><au>Huestis, Marilyn</au><au>Strauss, Arthur</au><au>Della Grotta, Sheri</au><au>Dansereau, Lynne M</au><au>Lin, Hai</au><au>Lester, Barry M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine</atitle><jtitle>Neurotoxicology and teratology</jtitle><addtitle>Neurotoxicol Teratol</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>33</volume><issue>1</issue><spage>176</spage><epage>184</epage><pages>176-184</pages><issn>0892-0362</issn><eissn>1872-9738</eissn><abstract>Abstract Background Methamphetamine (MA) use among pregnant women is an increasing problem in the United States. The impact of prenatal MA exposure on development in childhood is unknown. Objective To examine the effects of prenatal MA exposure on motor and cognitive development in children at 1, 2, and 3 years of age. Design/methods IDEAL enrolled 412 mother–infant pairs at four sites (Tulsa OK, Des Moines IA, Los Angeles CA, and Honolulu HI). MA subjects (n = 204) were identified by self report or GC/MS confirmation of amphetamine and metabolites in infant meconium. Comparison subjects (n = 208) were matched (race, birth weight, maternal education, and type of insurance), denied amphetamine use, and had a negative meconium screen. Both groups included prenatal alcohol, tobacco and marijuana use, but excluded use of opiates, lysergic acid diethylamide, phencyclidine or cocaine only. The Peabody Developmental Motor Scales (PDMS-2) were administered to the infants at the 1 and 3 year visits. This analysis includes a subsample (n = 350) of the IDEAL study with completed 1 and/or 3 year visits (n = 330 and 281, respectively). At each annual visit we also conducted the Bayley Scales of Infant Development (BSID-II) as a general evaluation of mental and motor development. The BSID-II analysis includes a subsample (n = 356) of the IDEAL study with completed 1, 2, and/or 3 year visits (n = 331, 288, and 278 respectively). GLM analysis conducted on the PDMS-2 and BSID-II examined the effects of MA exposure and heavy MA exposure (≥ 3 days of use/week), with and without covariates. Longitudinal analyses were used to examine the effects of MA exposure on changes in motor and cognitive performance over time. Results Heavy MA exposure was associated with significantly lower grasping scores than some and no use at 1 year (P = 0.018). In longitudinal analysis, lower grasping scores associated with any MA exposure and heavy exposure persisted to 3 years. There were no effects of MA exposure, including heavy exposure, on the Bayley Mental Development Index (MDI) or Psychomotor Development Index (PDI) at any or across age. Conclusions There were no differences in cognition as assessed by the BSID-II between the groups. There was a subtle MA exposure effect on fine motor performance at 1 year with the poorest performance observed in the most heavily exposed children. By 3 years, no differences in fine motor performance were observed. These findings suggest MA exposure has modest motor effects at 1 year that are mostly resolved by 3 years.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21256431</pmid><doi>10.1016/j.ntt.2010.10.004</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0892-0362 |
ispartof | Neurotoxicology and teratology, 2011-01, Vol.33 (1), p.176-184 |
issn | 0892-0362 1872-9738 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3033584 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Bayley Case-Control Studies Child Behavior - drug effects Child Behavior - psychology Child Development - drug effects Child, Preschool Cognition - drug effects Cross-Sectional Studies Emergency Female Humans Infant Infant Behavior - drug effects Infant Behavior - psychology Infant, Newborn Longitudinal Studies Male Medical Education Methamphetamine - toxicity Motor Activity - drug effects Neurodevelopment Peabody Pregnancy Prenatal exposure Prenatal Exposure Delayed Effects - chemically induced Prenatal Exposure Delayed Effects - physiopathology Prenatal Exposure Delayed Effects - psychology Social Class Surveys and Questionnaires |
title | Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T13%3A54%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Motor%20and%20cognitive%20outcomes%20through%20three%20years%20of%20age%20in%20children%20exposed%20to%20prenatal%20methamphetamine&rft.jtitle=Neurotoxicology%20and%20teratology&rft.au=Smith,%20Lynne%20M&rft.date=2011-01-01&rft.volume=33&rft.issue=1&rft.spage=176&rft.epage=184&rft.pages=176-184&rft.issn=0892-0362&rft.eissn=1872-9738&rft_id=info:doi/10.1016/j.ntt.2010.10.004&rft_dat=%3Cproquest_pubme%3E860378466%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=860378466&rft_id=info:pmid/21256431&rft_els_id=1_s2_0_S0892036210001868&rfr_iscdi=true |